Showing results (511-520 of 941) with videos related to
Sort By:
Pageof 95
Neuroscience Letters|June 28, 2000
Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slicesS M Fitzjohn, R A Morton, F Kuenzi, et al.Brain Research|March 26, 2003
Hippocampal synaptic plasticity in mice carrying the rd mutation in the gene encoding cGMP phosphodiesterase type 6 (PDE6)Frederick Kuenzi, Thomas W Rosahl, Robin A Morton, et al.Journal of Adolescence|September 19, 2014
Latino cultural values as protective factors against sexual risks among adolescentsMindy Ma, Lydia R Malcolm, Kristine Diaz-Albertini, et al.The European Journal of Neuroscience|October 13, 2020
Aging-related changes in cortical mechanisms supporting postural control during base of support and optic flow manipulationsBrenda R Malcolm, John J Foxe, Sonja Joshi, et al.Journal of the American Chemical Society|August 15, 2002
XMCD characterization of the ferromagnetic state of Yb14MnSb11Aaron P Holm, Susan M Kauzlarich, Simon A Morton, et al.Journal of Orthopaedic Surgery and Research|November 14, 2019
Healthcare disparities among orthopedic trauma patients in the USA: socio-demographic factors influence the management of calcaneus fracturesBoris A Zelle, Nicolas A Morton-Gonzaba, Christopher F Adcock, et al.Trends in Plant Science|July 5, 2021
Exploring environmental selection on genome size in angiospermsLubna Faizullah, Joseph A Morton, Erika I Hersch-Green, et al.Neuropharmacology|December 10, 1999
Regulation of depolarizing GABA(A) receptor-mediated synaptic potentials by synaptic activation of GABA(B) autoreceptors in the rat hippocampusS R Cobb, N A Manuel, R A Morton, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 13, 2012
GABA is excitatory in adult vasopressinergic neuroendocrine cellsJuhee Haam, Ion R Popescu, Linda A Morton, et al.The Journal of Urology|October 22, 2011
Toremifene decreases vertebral fractures in men younger than 80 years receiving androgen deprivation therapy for prostate cancerMatthew R Smith, S Bruce Malkowicz, Michael K Brawer, et al.Pageof 95